Tag Archives: data

For years, Johnson & Johnson and the Pfizer-Astellas team have been the only players in their class of prostate-cancer fighters. But Bayer is waiting in the wings, and stellar new safety data could make it a threat. The German drugmaker trumpeted phase 3 data Thursday on its androgen receptor antagonist candidate, darolutamide, showing that the drug… Read More »

Investors panicked back in October when Bristol-Myers Squibb admitted that a request for additional data from a key lung cancer trial had pushed back an FDA decision. And perhaps rightly so. Thursday, the company said it had voluntarily pulled its application for an Opdivo-Yervoy pairing in a subset of patients with previously untreated non-small cell lung… Read More »

As networks have advanced in complexity, so have the tools and tactics of cybercriminals. Organizations increase their cybersecurity budgets and teams, yet breaches keep occurring. In the fight for stronger security, vendors are offering up AI and machine learning as a Holy Grail. But do these technologies actually deliver? Frequent headlines make it clear that… Read More »